drug approvals

FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
BioPharma Dive
Wed, 01/4/23 - 10:11 am
FDA
drug approvals
HIV
lymphoma
multiple sclerosis
Gilead Sciences
Roche
TG Therapeutics
FDA commissioner on drug approvals: The problem isn't innovation or speed
Endpoints
Thu, 12/8/22 - 11:15 pm
FDA
Robert Califf
innovation
drug approvals
Brace for an end-of-year boost to drug approvals
EP Vantage
Fri, 09/2/22 - 12:14 pm
FDA
drug approvals
Alnylam Pharmaceuticals
Apellis Pharmaceuticals
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
Mirati Therapeutics
Moderna Therapeutics
Provention Bio
Roche
TG Therapeutics
Travere Therapeutics
Biotech Looks to Bounce Back in Second Half of 2022
BioSpace
Mon, 08/22/22 - 09:43 am
biotech
M&A
drug approvals
Drugmakers are slow to prove medicines that got a fast track to market really work
NPR
Sun, 07/24/22 - 07:52 pm
FDA
drug approvals
accelerated approvals
fast track
cancer
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
FDA
drug approvals
Amicus
Bluebird Bio
Bristol Myers Squibb
Eli Lilly
Marinus Pharma
Amylyx
Novartis
BIO research outlines risks in changing accelerated approval pathway
Biopharma Reporter
Tue, 06/21/22 - 12:04 pm
BIO Conference
FDA
drug approvals
accelerated approvals
Study: FDA approves new oncology drugs quicker than EMA
RAPS.org
Mon, 06/13/22 - 10:33 am
JAMA
regulatory
drug approvals
FDA
EMA
Europe
FDA Approvals Roundup: Camzyos, Vivjoa, Epsolay
RAPS.org
Thu, 05/5/22 - 10:23 am
FDA
drug approvals
Bristol Myers Squibb
Camzyos
Mycovia
Vivjoa
Sol-Gel
Epsolay
FDA's use of adcomms prior to drug approval decreased over the last decade
RAPS.org
Tue, 05/3/22 - 10:49 pm
FDA
regulatory
advisory panels
drug approvals
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
Will the COVID-19 Vaccine Speed Up Biotech Production?
Motley Fool
Wed, 02/23/22 - 10:04 pm
vaccines
COVID-19
drug approvals
drug development
China-Developed Drugs for U.S. Market Could Face Steep Hill
BioSpace
Wed, 02/9/22 - 11:01 am
China
drug approvals
FDA
clinical trials
Cancer therapies lead way as FDA tallies 60 drug approvals in 2021
MedCity News
Sun, 01/2/22 - 11:31 pm
FDA
drug approvals
cancer
oncology
Federal watchdog will review the controversial FDA approval of Biogen’s Alzheimer’s drug
Stat
Wed, 08/4/21 - 10:44 pm
Biogen
Aduhelm
FDA
drug approvals
Alzheimer's disease
'Erratic' FDA and inconsistent drug decisions put doctors off new meds: survey
Fierce Pharma
Tue, 08/3/21 - 11:49 pm
FDA
trust
physicians
drug approvals
Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report
Fierce Pharma
Thu, 07/15/21 - 12:39 pm
Novartis
AbbVie
GSK
Roche
Eli Lilly
AstraZeneca
FDA
drug launches
drug approvals
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
FDA
drug approvals
Bayer
Kerendia
Astellas
Padcev
Teva Pharmaceutical
ArmonAir RespiClick
Janssen
Darzalex Faspro
FDA staffers defend Aduhelm approval in JAMA editorial
Pharmaforum
Wed, 07/14/21 - 10:18 am
FDA
Biogen
Aduhelm
JAMA
drug approvals
Alzheimer's disease
Novartis leads and Bristol lags on novel drug approvals
EP Vantage
Wed, 07/14/21 - 10:10 am
Novartis
Bristol Myers Squibb
drug approvals
FDA

Pages